Best Vascular/Novoste Marks 25 Years Since FDA Approval of Vascular Brachytherapy [Yahoo! Finance]
Cardinal Health, Inc. (CAH)
Last cardinal health, inc. earnings: 2/6 06:55 am
Check Earnings Report
US:NYSE Investor Relations:
ir.cardinalhealth.com/home
Company Research
Source: Yahoo! Finance
Washington, D.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- This month marks a major milestone in cardiovascular medicine: 25 years since the U.S. Food and Drug Administration (FDA) approved vascular brachytherapy (VBT) for treating in-stent coronary artery restenosis—a condition that can re-narrow arteries after stent placement. Best Vascular/Novoste Marks 25 Years Since FDA Approval of Vascular Brachytherapy www.bestvascular.com It all began more than three decades ago, when pioneering researchers began exploring how radiation could safely be used to improve outcomes for heart patients. In 1994, Dr. Paul Teirstein of Scripps Clinic in La Jolla, California, in partnership with Best Medical International (BMI), launched the first randomized, double-blind Phase 1 human clinical trial using Iridium-192 seeds in nylon ribbons. Around the same time, Dr. Ron Waksman at Emory University in Atlanta, Georgia, was conducting complementary animal studies using the same BMI technology. The earl
Show less
Read more
Impact Snapshot
Event Time:
CAH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAH alerts
High impacting Cardinal Health, Inc. news events
Weekly update
A roundup of the hottest topics
CAH
News
- Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve [Yahoo! Finance]Yahoo! Finance
- Citius Oncology rises after U.S. launch of Lymphir as a cancer treatment [Seeking Alpha]Seeking Alpha
- Top Healthcare revenue stocks as hedge funds sell Tech stocks to buy the sector [Seeking Alpha]Seeking Alpha
- Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy? [Yahoo! Finance]Yahoo! Finance
CAH
Earnings
- 10/30/25 - Beat
CAH
Sec Filings
- 12/2/25 - Form 4
- 12/2/25 - Form 4
- 12/2/25 - Form 4
- CAH's page on the SEC website